Investegate |Indivior PLC Announcements | Indivior PLC: Final Results
Investegate announcements from Indivior PLC, Final Results
Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Indivior PLC, Final Results
The group has posted a rise in annual sales today, having seen its bottom line buoyed by strong sales of its newer injectable therapy.
Consumer prices rose at the fastest annual pace in nearly 30 years last month as inflation hit 5.5 per cent, up from 5.4 per cent in December, the ONS said.
Shares in the FTSE250 group, which makes drugs to treat opioid addiction, shot up 14.1pc to 259.8p after boss Mark Crossley said a secondary listing on the US market was 'likely' to benefit the group.
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of data from a clinical pharmacology study designed to assess the ability of...